Abstract:
Objective To reveal the expression and the clinical significance of aquaporin 3 (AQP 3) in cervical carcinoma tissues from Uygur patients.
Methods The expression of AQP3 in 10 cases with chronic cervical inflammation and 27 cases of cervical carcinoma was determined using real-time PCR, Western blot analysis, and immunofluorescence. The expression of AQP3 protein in 82 cases with cervical carcinoma, 36 cases with Stage-III cervical intraepithelial neoplasia (CINⅢ), and 42 cases with chronic cervical inflammation, was assayed using immunohistochemistry.
Results AQP3 mRNA and protein were expressed in both the chronic cervical inflammation and cervical carcinoma groups. The AQP3 protein expression was statistically significant (P < 0.05), whereas the AQP3 mRNA expression was not (P>0.05). Moreover, the positive rate of AQP3 was 19.00%, 27.78%, and 41.46% in the chronic cervical inflammation, CIN Ⅲ, and cervical carcinoma groups, respectively, with significant differences among the positive expression (P < 0.05). The expression of AQP3 in cervical carcinoma had no correlation with histological grade, histological type, or lymph node metastasis (P>0.05), however, it had significant association with FIGO stage, diameter of tumor, and invasive depth (P < 0.05).
Conclusion The expression of AQP3 plays an important role in the carcinogenesis and progression of cervical carcinoma.